Genetic and epigenetic basis of psoriasis pathogenesis

Molecular Immunology

Volumn 64, Issue 2, 2015, Pages 313-323

  Chandra, Aditi ^a   Ray, Aditi ^a   Senapati, Swapan ^b   Chatterjee, Raghunath ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b Consultant Dermatologist ^*  (India)

Author keywords

DNA methylation; Generalized plaque type psoriasis; Genome wide association study; Histone modifications; Micro RNA; Single nucleotide polymorphism

Indexed keywords

MICRORNA; CHROMATIN;

CHROMATIN; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISTONE MODIFICATION; HUMAN; META ANALYSIS (TOPIC); PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; AGE; CHEMISTRY; FEMALE; GENETIC EPIGENESIS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; SEX DIFFERENCE; SKIN;

AGE FACTORS; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; PSORIASIS; SEX FACTORS; SKIN;

EID: 84921059269     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.12.014     Document Type: Review

References (173)

1. Abele D.C., Dobson R.L., Graham J.B. Heredity and psoriasis study of a large family. Arch. Dermatol. 1963, 88:38-47.
2. Ammar M., Bouchlaka-Souissi C., Helms C.A., Zaraa I., Jordan C.T., Anbunathan H., Bouhaha R., Kouidhi S., Doss N., Dhaoui R., Ben Osman A., Ben Ammar El Gaied A., Marrakchi R., Mokni M., Bowcock A.M. Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families. Br. J. Dermatol. 2013, 168:583-587.
3. Ammar M., Bouchlaka-Souissi C., Zaraa I., Helms C., Doss N., Bouazizi F., Dhaoui R., Ossman A.B., Ammar-el Gaied A.B., Mokni M. Family-based association study in Tunisian familial psoriasis. Int. J. Dermatol. 2012, 51:1329-1334.
4. Aschner B., Curth H.O., Gross P. Genetic aspects of psoriasis. Acta Genet. Stat. Med. 1957, 7,:197-202. (discussion 202-204).
5. Asumalahti K., Laitinen T., Lahermo P., Suomela S., Itkonen-Vatjus R., Jansen C., Karvonen J., Karvonen S.L., Reunala T., Snellman E., Uurasmaa T., Saarialho-Kere U., Kere J. Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. J. Invest. Dermatol. 2003, 121:735-740.
6. Asumalahti K., Veal C., Laitinen T., Suomela S., Allen M., Elomaa O., Moser M., de Cid R., Ripatti S., Vorechovsky I., Marcusson J.A., Nakagawa H., Lazaro C., Estivill X., Capon F., Novelli G., Saarialho-Kere U., Barker J., Trembath R., Kere J. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum. Mol. Genet. 2002, 11:589-597.
7. Backendorf C., Hohl D. A common origin for cornified envelope proteins?. Nat. Genet. 1992, 2:91.
8. Bhalerao J., Bowcock A.M. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum. Mol. Genet. 1998, 7:1537-1545.
9. 2 zinc finger protein. Nat. Genet. 2006, 38:749-751.
10. Blander G., Bhimavarapu A., Mammone T., Maes D., Elliston K., Reich C., Matsui M.S., Guarente L., Loureiro J.J. SIRT1 promotes differentiation of normal human keratinocytes. J. Invest. Dermatol. 2009, 129:41-49.
11. Borgiani P., Vallo L., D'Apice M.R., Giardina E., Pucci S., Capon F., Nistico S., Chimenti S., Pallone F., Novelli G. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 2002, 12:540-542.
12. Bowcock A.M. The genetics of psoriasis and autoimmunity. Annu. Rev. Genomics Hum. Genet. 2005, 6:93-122.
13. Bowcock A.M., Cookson W.O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 2004, 13(Spec No. 1):R43-R55.
14. Butt C., Peddle L., Greenwood C., Hamilton S., Gladman D., Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res. Ther. 2006, 8:R27.
15. Capon F., Bijlmakers M.J., Wolf N., Quaranta M., Huffmeier U., Allen M., Timms K., Abkevich V., Gutin A., Smith R., Warren R.B., Young H.S., Worthington J., Burden A.D., Griffiths C.E., Hayday A., Nestle F.O., Reis A., Lanchbury J., Barker J.N., Trembath R.C. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum. Mol. Genet. 2008, 17:1938-1945.
16. Capon F., Di Meglio P., Szaub J., Prescott N.J., Dunster C., Baumber L., Timms K., Gutin A., Abkevic V., Burden A.D., Lanchbury J., Barker J.N., Trembath R.C., Nestle F.O. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 2007, 122:201-206.
17. Capon F., Helms C., Veal C.D., Tillman D., Burden A.D., Barker J.N., Bowcock A.M., Trembath R.C. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J. Med. Genet. 2004, 41:459-460.
18. Capon F., Novelli G., Semprini S., Clementi M., Nudo M., Vultaggio P., Mazzanti C., Gobello T., Botta A., Fabrizi G., Dallapiccola B. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J. Invest. Dermatol. 1999, 112:32-35.
19. Capon F., Semprini S., Chimenti S., Fabrizi G., Zambruno G., Murgia S., Carcassi C., Fazio M., Mingarelli R., Dallapiccola B., Novelli G. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J. Invest. Dermatol. 2001, 116:728-730.
20. Capon F., Semprini S., Dallapiccola B., Novelli G. Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am. J. Hum. Genet. 1999, 65:1798-1800.
21. Capon F., Trembath R.C., Barker J.N. An update on the genetics of psoriasis. Dermatol. Clin. 2004, 22:339-347. vii.
22. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., Matsunami N., Ardlie K.G., Civello D., Catanese J.J., Leong D.U., Panko J.M., McAllister L.B., Hansen C.B., Papenfuss J., Prescott S.M., White T.J., Leppert M.F., Krueger G.G., Begovich A.B. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 2007, 80:273-290.
23. Caruso R., Botti E., Sarra M., Esposito M., Stolfi C., Diluvio L., Giustizieri M.L., Pacciani V., Mazzotta A., Campione E., Macdonald T.T., Chimenti S., Pallone F., Costanzo A., Monteleone G. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 2009, 15:1013-1015.
24. Chandran V., Raychaudhuri S.P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J. Autoimmun. 2010, 34:J314-J321.
25. Chang Y.T., Hsu C.Y., Chou C.T., Lin M.W., Shiao Y.M., Tsai C.Y., Yu C.W., Shiue J.J., Lee Y.F., Huang C.H., Chen C.C., Lee D.D., Wang W.J., Liu H.N., Tsai S.F. The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in Chinese. J. Dermatol. Sci. 2007, 46:153-156.
26. Chang Y.T., Shiao Y.M., Chin P.J., Liu Y.L., Chou F.C., Wu S., Lin Y.F., Li L.H., Lin M.W., Liu H.N., Tsai S.F. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 2004, 150:1104-1111.
27. Chatterjee R., Vinson C. CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim. Biophys. Acta 2012, 1819:763-770.
28. Chen H., Toh T.K., Szeverenyi I., Ong R.T., Theng C.T., McLean W.H., Seielstad M., Lane E.B. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J. Invest. Dermatol. 2009, 129:606-614.
29. Chen M., Chen Z.Q., Cui P.G., Yao X., Li Y.M., Li A.S., Gong J.Q., Cao Y.H. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br. J. Dermatol. 2008, 158:987-993.
30. Choi H.R., Nam K.M., Park S.J., Kim D.S., Huh C.H., Park W.Y., Park K.C. Suppression of miR135b increases the proliferative potential of normal human keratinocytes. J. Invest. Dermatol. 2013, 134:1161-1164.
31. I.P.G.Consortium The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am. J. Hum. Genet. 2003, 73:430-437.
32. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., Giardina E., Stuart P.E., Nair R., Helms C., Escaramis G., Ballana E., Martin-Ezquerra G., den Heijer M., Kamsteeg M., Joosten I., Eichler E.E., Lazaro C., Pujol R.M., Armengol L., Abecasis G., Elder J.T., Novelli G., Armour J.A., Kwok P.Y., Bowcock A., Schalkwijk J., Estivill X. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 2009, 41:211-215.
33. Deng W., Liang W.B., Gao L.B., Wang Y.Y., Lv M.L., Zhu Y., Zhang L. Association of ADAM33 polymorphisms and susceptibility to psoriasis. DNA Cell Biol. 2010, 29:435-439.
34. Duffy D.L., Spelman L.S., Martin N.G. Psoriasis in Australian twins. J. Am. Acad. Dermatol. 1993, 29:428-434.
35. Elder J.T. IL-15 and psoriasis: another genetic link to Th17?. J. Invest. Dermatol. 2007, 127:2495-2497.
36. Ellinghaus D., Ellinghaus E., Nair R.P., Stuart P.E., Esko T., Metspalu A., Debrus S., Raelson J.V., Tejasvi T., Belouchi M., West S.L., Barker J.N., Koks S., Kingo K., Balschun T., Palmieri O., Annese V., Gieger C., Wichmann H.E., Kabesch M., Trembath R.C., Mathew C.G., Abecasis G.R., Weidinger S., Nikolaus S., Schreiber S., Elder J.T., Weichenthal M., Nothnagel M., Franke A. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am. J. Hum. Genet. 2012, 90:636-647.
37. Ellinghaus E., Ellinghaus D., Stuart P.E., Nair R.P., Debrus S., Raelson J.V., Belouchi M., Fournier H., Reinhard C., Ding J., Li Y., Tejasvi T., Gudjonsson J., Stoll S.W., Voorhees J.J., Lambert S., Weidinger S., Eberlein B., Kunz M., Rahman P., Gladman D.D., Gieger C., Wichmann H.E., Karlsen T.H., Mayr G., Albrecht M., Kabelitz D., Mrowietz U., Abecasis G.R., Elder J.T., Schreiber S., Weichenthal M., Franke A. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 2010, 42:991-995.
38. Elomaa O., Majuri I., Suomela S., Asumalahti K., Jiao H., Mirzaei Z., Rozell B., Dahlman-Wright K., Pispa J., Kere J., Saarialho-Kere U. Transgenic mouse models support HCR as an effector gene in the PSORS1 locus. Hum. Mol. Genet. 2004, 13:1551-1561.
39. Enerback C., Nilsson S., Enlund F., Inerot A., Samuelsson L., Wahlstrom J., Swanbeck G., Martinsson T. Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch. Dermatol. Res. 2000, 292:525-530.
40. Engelkamp D., Schafer B.W., Mattei M.G., Erne P., Heizmann C.W. Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6547-6551.
41. Enlund F., Samuelsson L., Enerback C., Inerot A., Wahlstrom J., Yhr M., Torinsson A., Martinsson T., Swanbeck G. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q. Hum. Hered. 1999, 49:2-8.
42. Enlund F., Samuelsson L., Enerback C., Inerot A., Wahlstrom J., Yhr M., Torinsson A., Riley J., Swanbeck G., Martinsson T. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur. J. Hum. Genet. 1999, 7:783-790.
43. Fan X., Yang S., Huang W., Wang Z.M., Sun L.D., Liang Y.H., Gao M., Ren Y.Q., Zhang K.Y., Du W.H., Shen Y.J., Liu J.J., Zhang X.J. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population. PLoS Genet. 2008, 4:e1000038.
44. Feng B.J., Sun L.D., Soltani-Arabshahi R., Bowcock A.M., Nair R.P., Stuart P., Elder J.T., Schrodi S.J., Begovich A.B., Abecasis G.R., Zhang X.J., Callis-Duffin K.P., Krueger G.G., Goldgar D.E. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet. 2009, 5:e1000606.
45. Gandhi G., Buttar B.S., Albert L., Hasan Q., Aggarwal R.K. Psoriasis-associated genetic polymorphism in North Indian population in the CCHCR1 gene and in a genomic segment flanking the HLA-C region. Dis. Markers 2011, 31:361-370.
46. Gervin K., Vigeland M.D., Mattingsdal M., Hammero M., Nygard H., Olsen A.O., Brandt I., Harris J.R., Undlien D.E., Lyle R. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet. 2012, 8:e1002454.
47. Giardina E., Capon F., De Rosa M.C., Mango R., Zambruno G., Orecchia A., Chimenti S., Giardina B., Novelli G. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann. Hum. Genet. 2004, 68:639-645.
48. Giardina E., Predazzi I., Sinibaldi C., Peconi C., Amerio P., Costanzo A., Paradisi A., Capizzi R., Paradisi M., Chimenti S., Taccari E., Novelli G. PSORS2 markers are not associated with psoriatic arthritis in the Italian population. Hum. Hered. 2006, 61:120-122.
49. Gonzalez S., Martinez-Borra J., Del Rio J.S., Santos-Juanes J., Lopez-Vazquez A., Blanco-Gelaz M., Lopez-Larrea C. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J. Invest. Dermatol. 2000, 115:824-828.
50. Gottlieb A.B., Krueger J.G. HLA region genes and immune activation in the pathogenesis of psoriasis. Arch. Dermatol. 1990, 126:1083-1086.
51. Grayson L.D., Shair H.M. Psoriatic family tree. AMA Arch. Dermatol. 1959, 79:661-664.
52. Gudjonsson J.E., Krueger G. A role for epigenetics in psoriasis: methylated cytosine-guanine sites differentiate lesional from nonlesional skin and from normal skin. J. Invest. Dermatol. 2012, 132:506-508.
53. Haggarty P., Ferguson-Smith A.C. Life course epigenetics and healthy ageing. A Life Course Approach to Healthy Ageing 2013, 198-212. D. Kuh, R. Cooper, R. Hardy, M. Richards, Y. Ben-Shlomo (Eds.).
54. Han J., Park S.G., Bae J.B., Choi J., Lyu J.M., Park S.H., Kim H.S., Kim Y.J., Kim S., Kim T.Y. The characteristics of genome-wide DNA methylation in naive CD4+ T cells of patients with psoriasis or atopic dermatitis. Biochem. Biophys. Res. Commun. 2012, 422:157-163.
55. Han J., Xiao J., Wu Q., Hao L. Association of ADAM33 gene polymorphisms with psoriasis in a northeastern Chinese population. Mol. Biol. Rep. 2014, 41:4001-4005.
56. Hebert H.L., Ali F.R., Bowes J., Griffiths C.E., Barton A., Warren R.B. Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br. J. Dermatol. 2012, 166:474-482.
57. Helms C., Cao L., Krueger J.G., Wijsman E.M., Chamian F., Gordon D., Heffernan M., Daw J.A., Robarge J., Ott J., Kwok P.Y., Menter A., Bowcock A.M. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 2003, 35:349-356.
58. Henseler T., Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 1985, 13:450-456.
59. Hewett D., Samuelsson L., Polding J., Enlund F., Smart D., Cantone K., See C.G., Chadha S., Inerot A., Enerback C., Montgomery D., Christodolou C., Robinson P., Matthews P., Plumpton M., Wahlstrom J., Swanbeck G., Martinsson T., Roses A., Riley J., Purvis I. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 2002, 79:305-314.
60. Hou R., Yin G., An P., Wang C., Liu R., Yang Y., Yan X., Li J., Li X., Zhang K. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes. J. Dermatol. Sci. 2013, 72:103-109.
61. Hu Z., Xiong Z., Xu X., Li F., Lu L., Li W., Su J., Liu Y., Liu D., Xie Z., Peng Y., Kuang Y., Wu L., Zhang J., Pan Q., Tang B., Chen X., Xia K. Loss-of-function mutations in filaggrin gene associate with psoriasis vulgaris in Chinese population. Hum. Genet. 2012, 131:1269-1274.
62. Huffmeier U., Lascorz J., Becker T., Schurmeier-Horst F., Magener A., Ekici A.B., Endele S., Thiel C.T., Thoma-Uszynski S., Mossner R., Reich K., Kurrat W., Wienker T.F., Traupe H., Reis A. Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. J. Med. Genet. 2009, 46:736-744.
63. Huffmeier U., Lascorz J., Bohm B., Lohmann J., Wendler J., Mossner R., Reich K., Traupe H., Kurrat W., Burkhardt H., Reis A. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J. Invest. Dermatol. 2009, 129:355-358.
64. Huffmeier U., Lascorz J., Traupe H., Bohm B., Schurmeier-Horst F., Stander M., Kelsch R., Baumann C., Kuster W., Burkhardt H., Reis A. Systematic linkage disequilibrium analysis of SLC12A8 at PSORS5 confirms a role in susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 2005, 125:906-912.
65. Huffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., Juneblad K., Apel M., McManus R., Ho P., Bruce I.N., Ryan A.W., Behrens F., Lascorz J., Bohm B., Traupe H., Lohmann J., Gieger C., Wichmann H.E., Herold C., Steffens M., Klareskog L., Wienker T.F., Fitzgerald O., Alenius G.M., McHugh N.J., Novelli G., Burkhardt H., Barton A., Reis A. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 2010, 42:996-999.
66. Hwu W.L., Yang C.F., Fann C.S., Chen C.L., Tsai T.F., Chien Y.H., Chiang S.C., Chen C.H., Hung S.I., Wu J.Y., Chen Y.T. Mapping of psoriasis to 17q terminus. J. Med. Genet. 2005, 42:152-158.
67. Ichihara A., Jinnin M., Oyama R., Yamane K., Fujisawa A., Sakai K., Masuguchi S., Fukushima S., Maruo K., Ihn H. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur. J. Dermatol. 2012, 22:68-71.
68. Ichihara A., Jinnin M., Yamane K., Fujisawa A., Sakai K., Masuguchi S., Fukushima S., Maruo K., Ihn H. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br. J. Dermatol. 2011, 165:1003-1010.
69. Jenisch S., Henseler T., Nair R.P., Guo S.W., Westphal E., Stuart P., Kronke M., Voorhees J.J., Christophers E., Elder J.T. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am. J. Hum. Genet. 1998, 63:191-199.
70. Jordan C.T., Cao L., Roberson E.D., Duan S., Helms C.A., Nair R.P., Duffin K.C., Stuart P.E., Goldgar D., Hayashi G., Olfson E.H., Feng B.J., Pullinger C.R., Kane J.P., Wise C.A., Goldbach-Mansky R., Lowes M.A., Peddle L., Chandran V., Liao W., Rahman P., Krueger G.G., Gladman D., Elder J.T., Menter A., Bowcock A.M. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am. J. Hum. Genet. 2012, 90:796-808.
71. Jordan C.T., Cao L., Roberson E.D., Pierson K.C., Yang C.F., Joyce C.E., Ryan C., Duan S., Helms C.A., Liu Y., Chen Y., McBride A.A., Hwu W.L., Wu J.Y., Chen Y.T., Menter A., Goldbach-Mansky R., Lowes M.A., Bowcock A.M. PSORS2 is due to mutations in CARD14. Am. J. Hum. Genet. 2012, 90:784-795.
72. Joyce C.E., Zhou X., Xia J., Ryan C., Thrash B., Menter A., Zhang W., Bowcock A.M. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum. Mol. Genet. 2011, 20:4025-4040.
73. Kim Y.K., Pyo C.W., Choi H.B., Kim S.Y., Kim T.Y., Kim T.G. Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. J. Dermatol. Sci. 2007, 48:133-139.
74. Kimberling W., Dobson R.L. The inheritance of psoriasis. J. Invest. Dermatol. 1973, 60:538-540.
75. Kofink D., Boks M.P., Timmers H., Kas M.J. Epigenetic dynamics in psychiatric disorders: environmental programming of neurodevelopmental processes. Neurosci. Biobehav. Rev. 2013, 37:831-845.
76. Koga Y., Jinnin M., Ichihara A., Fujisawa A., Moriya C., Sakai K., Fukushima S., Inoue Y., Ihn H. Analysis of expression pattern of serum microRNA levels in patients with psoriasis. J. Dermatol. Sci. 2014, 74:170-171.
77. Lee Y.A., Ruschendorf F., Windemuth C., Schmitt-Egenolf M., Stadelmann A., Nurnberg G., Stander M., Wienker T.F., Reis A., Traupe H. Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am. J. Hum. Genet. 2000, 67:1020-1024.
78. Lena A.M., Shalom-Feuerstein R., Rivetti di Val Cervo P., Aberdam D., Knight R.A., Melino G., Candi E. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ. 2008, 15:1187-1195.
79. Lerman G., Avivi C., Mardoukh C., Barzilai A., Tessone A., Gradus B., Pavlotsky F., Barshack I., Polak-Charcon S., Orenstein A., Hornstein E., Sidi Y., Avni D. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS ONE 2011, 6:e20916.
80. Lesueur F., Lefevre C., Has C., Guilloud-Bataille M., Oudot T., Mahe E., Lahfa M., Mansouri S., Mosharraf-Olmolk H., Sobel E., Heath S., Lathrop M., Dizier M.H., Prud'Homme J.F., Fischer J. Confirmation of psoriasis susceptibility loci on chromosome 6p21 and 20p13 in French families. J. Invest. Dermatol. 2007, 127:1403-1409.
81. Li M., Wu Y., Chen G., Yang Y., Zhou D., Zhang Z., Zhang D., Chen Y., Lu Z., He L., Zheng J., Liu Y. Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population. J. Invest. Dermatol. 2011, 131:1639-1643.
82. Li Y., Liao W., Cargill M., Chang M., Matsunami N., Feng B.J., Poon A., Callis-Duffin K.P., Catanese J.J., Bowcock A.M., Leppert M.F., Kwok P.Y., Krueger G.G., Begovich A.B. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J. Invest. Dermatol. 2010, 130:2768-2772.
83. Li Y., Liao W., Chang M., Schrodi S.J., Bui N., Catanese J.J., Poon A., Matsunami N., Callis-Duffin K.P., Leppert M.F., Bowcock A.M., Kwok P.Y., Krueger G.G., Begovich A.B. Further genetic evidence for three psoriasis-risk genes: ADAM33 CDKAL1, and PTPN22. J. Invest. Dermatol. 2009, 129:629-634.
84. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., Wise C., Miner A., Malloy M.J., Pullinger C.R., Kane J.P., Saccone S., Worthington J., Bruce I., Kwok P.Y., Menter A., Krueger J., Barton A., Saccone N.L., Bowcock A.M. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008, 4:e1000041.
85. Lonnberg A.S., Skov L., Skytthe A., Kyvik K.O., Pedersen O.B., Thomsen S.F. Heritability of psoriasis in a large twin sample. Br. J. Dermatol. 2013, 169:412-416.
86. Lowes M.A., Russell C.B., Martin D.A., Towne J.E., Krueger J.G. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 2013, 34:174-181.
87. Lu Q. The critical importance of epigenetics in autoimmunity. J. Autoimmun. 2013, 41:1-5.
88. Magalhaes R.F., Biral A.C., Pancoto J.A., Donadi E.A., Mendes C.T., Magna L.A., Kraemer M.H. Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha-238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study. Int. J. Dermatol. 2010, 49:1133-1140.
89. Mak R.K., Hundhausen C., Nestle F.O. Progress in understanding the immunopathogenesis of psoriasis. Actas Dermosifiliogr. 2009, 100(Suppl. 2):2-13.
90. Mallon E., Bunce M., Savoie H., Rowe A., Newson R., Gotch F., Bunker C.B. HLA-C and guttate psoriasis. Br. J. Dermatol. 2000, 143:1177-1182.
91. Matthews D., Fry L., Powles A., Weber J., McCarthy M., Fisher E., Davies K., Williamson R. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat. Genet. 1996, 14:231-233.
92. Matthews D., Fry L., Powles A., Weissenbach J., Williamson R. Confirmation of genetic heterogeneity in familial psoriasis. J. Med. Genet. 1995, 32:546-548.
93. Meisgen F., Xu N., Wei T., Janson P.C., Obad S., Broom O., Nagy N., Kauppinen S., Kemeny L., Stahle M., Pivarcsi A., Sonkoly E. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp. Dermatol. 2012, 21:312-314.
94. Mischke D., Korge B.P., Marenholz I., Volz A., Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (epidermal differentiation complex) on human chromosome 1q21. J. Invest. Dermatol. 1996, 106:989-992.
95. Morar N., Bowcock A.M., Harper J.I., Cookson W.O., Moffatt M.F. Investigation of the chromosome 17q25 PSORS2 locus in atopic dermatitis. J. Invest. Dermatol. 2006, 126:603-606.
96. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., Gudjonsson J.E., Li Y., Tejasvi T., Feng B.J., Ruether A., Schreiber S., Weichenthal M., Gladman D., Rahman P., Schrodi S.J., Prahalad S., Guthery S.L., Fischer J., Liao W., Kwok P.Y., Menter A., Lathrop G.M., Wise C.A., Begovich A.B., Voorhees J.J., Elder J.T., Krueger G.G., Bowcock A.M., Abecasis G.R. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 2009, 41:199-204.
97. Nair R.P., Henseler T., Jenisch S., Stuart P., Bichakjian C.K., Lenk W., Westphal E., Guo S.W., Christophers E., Voorhees J.J., Elder J.T. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 1997, 6:1349-1356.
98. Nair R.P., Stuart P., Henseler T., Jenisch S., Chia N.V., Westphal E., Schork N.J., Kim J., Lim H.W., Christophers E., Voorhees J.J., Elder J.T. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am. J. Hum. Genet. 2000, 66:1833-1844.
99. Nair R.P., Stuart P., Ogura Y., Inohara N., Chia N.V., Young L., Henseler T., Jenisch S., Christophers E., Voorhees J.J., Nunez G., Elder J.T. Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J. Invest. Dermatol. 2001, 117:1671-1672.
100. Nair R.P., Stuart P.E., Nistor I., Hiremagalore R., Chia N.V., Jenisch S., Weichenthal M., Abecasis G.R., Lim H.W., Christophers E., Voorhees J.J., Elder J.T. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 2006, 78:827-851.
101. Naldi L. Risk factors for psoriasis. Curr. Dermatol. Rep. 2013, 2:58-65.
102. Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 2004, 113:1664-1675.
103. Onoufriadis A., Simpson M.A., Burden A.D., Barker J.N., Trembath R.C., Capon F. Identification of rare, disease-associated variants in the promoter region of the RNF114 psoriasis susceptibility gene. J. Invest. Dermatol. 2012, 132:1297-1299.
104. Oudot T., Lesueur F., Guedj M., de Cid R., McGinn S., Heath S., Foglio M., Prum B., Lathrop M., Prud'homme J.F., Fischer J. An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders. J. Invest. Dermatol. 2009, 129:2637-2645.
105. Park G.T., Han J., Park S.G., Kim S., Kim T.Y. DNA methylation analysis of CD4+ T cells in patients with psoriasis. Arch. Dermatol. Res. 2014, 306:259-268.
106. Pedersen O.B., Svendsen A.J., Ejstrup L., Skytthe A., Junker P. On the heritability of psoriatic arthritis disease concordance among monozygotic and dizygotic twins. Ann. Rheum. Dis. 2008, 67:1417-1421.
107. Pietrzyk J.J., Turowski G., Kapinska-Mrowka M. Family studies in psoriasis II. Inheritance of HLA genotypes. Arch. Dermatol. Res. 1982, 273:295-300.
108. Pietrzyk J.J., Turowski G., Kapinska-Mrowka M., Rozanski B. Family studies in psoriasis I. Complex segregation analysis. Arch. Dermatol. Res. 1982, 273:287-294.
109. Pitchappan R.M., Koteeswaran A., Kakkaniah V.N., Manickasundari M., Rajaram V., Muthuveeralakshmi P., Mahendran V., Brahmajothibai V. HLA Bw57 and DR7 association with psoriasis vulgaris in south India. Tissue Antigens 1989, 34:133-137.
110. Pivarcsi A., Meisgen F., Xu N., Stahle M., Sonkoly E. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy. Br. J. Dermatol. 2013, 169:563-570.
111. Primo M.N., Bak R.O., Schibler B., Mikkelsen J.G. Regulation of pro-inflammatory cytokines TNFalpha and IL24 by microRNA-203 in primary keratinocytes. Cytokine 2012, 60:741-748.
112. Quaranta M., Burden A.D., Griffiths C.E., Worthington J., Barker J.N., Trembath R.C., Capon F. Differential contribution of CDKAL1 variants to psoriasis Crohn's disease and type II diabetes. Genes Immun. 2009, 10:654-658.
113. Rahman P., Bartlett S., Siannis F., Pellett F.J., Farewell V.T., Peddle L., Schentag C.T., Alderdice C.A., Hamilton S., Khraishi M., Tobin Y., Hefferton D., Gladman D.D. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am. J. Hum. Genet. 2003, 73:677-681.
114. Rani R., Narayan R., Fernandez-Vina M.A., Stastny P. Role of HLA-B and C alleles in development of psoriasis in patients from North India. Tissue Antigens 1998, 51:618-622.
115. Rishi V., Bhattacharya P., Chatterjee R., Rozenberg J., Zhao J., Glass K., Fitzgerald P., Vinson C. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20311-20316.
116. Roberson E.D., Liu Y., Ryan C., Joyce C.E., Duan S., Cao L., Martin A., Liao W., Menter A., Bowcock A.M. A subset of methylated CpG sites differentiate psoriatic from normal skin. J. Invest. Dermatol. 2012, 132:583-592.
117. Ruchusatsawat K., Wongpiyabovorn J., Protjaroen P., Chaipipat M., Shuangshoti S., Thorner P.S., Mutirangura A. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation. Hum. Pathol. 2011, 42:1878-1887.
118. Ruchusatsawat K., Wongpiyabovorn J., Shuangshoti S., Hirankarn N., Mutirangura A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J. Mol. Med. (Berl.) 2006, 84:175-182.
119. Ruiz D.G., Azevedo M.N., Lupi O. HLA-B27 frequency in a group of patients with psoriatic arthritis. An. Bras. Dermatol. 2012, 87:847-850.
120. Russell T.J., Schultes L.M., Kuban D.J. Histocompatibility (HL-A) antigens associated with psoriasis. N. Engl. J. Med. 1972, 287:738-740.
121. Sagoo G.S., Tazi-Ahnini R., Barker J.W., Elder J.T., Nair R.P., Samuelsson L., Traupe H., Trembath R.C., Robinson D.A., Iles M.M. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J. Invest. Dermatol. 2004, 122:1401-1405.
122. Samuelsson L., Stiller C., Friberg C., Nilsson C., Inerot A., Wahlstrom J. Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5. J. Invest. Dermatol. 2004, 122:1399-1400.
123. Sen G.L., Reuter J.A., Webster D.E., Zhu L., Khavari P.A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 2010, 463:563-567.
124. Shaiq P.A., Stuart P.E., Latif A., Schmotzer C., Kazmi A.H., Khan M.S., Azam M., Tejasvi T., Voorhees J.J., Raja G.K., Elder J.T., Qamar R., Nair R.P. Genetic associations of psoriasis in a Pakistani population. Br. J. Dermatol. 2013, 169:406-411.
125. Siroux V., Bouzigon E., Dizier M.H., Pin I., Demenais F., Kauffmann F. Replication of association between ADAM33 polymorphisms and psoriasis. PLoS ONE 2008, 3:e2448.
126. Smith R.L., Warren R.B., Eyre S., Ke X., Young H.S., Allen M., Strachan D., McArdle W., Gittins M.P., Barker J.N., Griffiths C.E., Worthington J. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br. J. Dermatol. 2008, 158:962-968.
127. Sonkoly E., Wei T., Janson P.C., Saaf A., Lundeberg L., Tengvall-Linder M., Norstedt G., Alenius H., Homey B., Scheynius A., Stahle M., Pivarcsi A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2007, 2:e610.
128. Speckman R.A., Wright Daw J.A., Helms C., Duan S., Cao L., Taillon-Miller P., Kwok P.Y., Menter A., Bowcock A.M. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum. Genet. 2003, 112:34-41.
129. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., Blackwell J.M., Bramon E., Bumpstead S.J., Casas J.P., Cork M.J., Corvin A., Deloukas P., Dilthey A., Duncanson A., Edkins S., Estivill X., Fitzgerald O., Freeman C., Giardina E., Gray E., Hofer A., Huffmeier U., Hunt S.E., Irvine A.D., Jankowski J., Kirby B., Langford C., Lascorz J., Leman J., Leslie S., Mallbris L., Markus H.S., Mathew C.G., McLean W.H., McManus R., Mossner R., Moutsianas L., Naluai A.T., Nestle F.O., Novelli G., Onoufriadis A., Palmer C.N., Perricone C., Pirinen M., Plomin R., Potter S.C., Pujol R.M., Rautanen A., Riveira-Munoz E., Ryan A.W., Salmhofer W., Samuelsson L., Sawcer S.J., Schalkwijk J., Smith C.H., Stahle M., Su Z., Tazi-Ahnini R., Traupe H., Viswanathan A.C., Warren R.B., Weger W., Wolk K., Wood N., Worthington J., Young H.S., Zeeuwen P.L., Hayday A., Burden A.D., Griffiths C.E., Kere J., Reis A., McVean G., Evans D.M., Brown M.A., Barker J.N., Peltonen L., Donnelly P., Trembath R.C. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 2010, 42:985-990.
130. Stuart P., Nair R.P., Abecasis G.R., Nistor I., Hiremagalore R., Chia N.V., Qin Z.S., Thompson R.A., Jenisch S., Weichenthal M., Janiga J., Lim H.W., Christophers E., Voorhees J.J., Elder J.T. Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage. J. Med. Genet. 2006, 43:12-17.
131. Stuart P.E., Nair R.P., Ellinghaus E., Ding J., Tejasvi T., Gudjonsson J.E., Li Y., Weidinger S., Eberlein B., Gieger C., Wichmann H.E., Kunz M., Ike R., Krueger G.G., Bowcock A.M., Mrowietz U., Lim H.W., Voorhees J.J., Abecasis G.R., Weichenthal M., Franke A., Rahman P., Gladman D.D., Elder J.T. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat. Genet. 2010, 42:1000-1004.
132. Sun C., Mathur P., Dupuis J., Tizard R., Ticho B., Crowell T., Gardner H., Bowcock A.M., Carulli J. Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Hum. Genet. 2006, 119:113-125.
133. Sun L.D., Cheng H., Wang Z.X., Zhang A.P., Wang P.G., Xu J.H., Zhu Q.X., Zhou H.S., Ellinghaus E., Zhang F.R., Pu X.M., Yang X.Q., Zhang J.Z., Xu A.E., Wu R.N., Xu L.M., Peng L., Helms C.A., Ren Y.Q., Zhang C., Zhang S.M., Nair R.P., Wang H.Y., Lin G.S., Stuart P.E., Fan X., Chen G., Tejasvi T., Li P., Zhu J., Li Z.M., Ge H.M., Weichenthal M., Ye W.Z., Shen S.K., Yang B.Q., Sun Y.Y., Li S.S., Lin Y., Jiang J.H., Li C.T., Chen R.X., Cheng J., Jiang X., Zhang P., Song W.M., Tang J., Zhang H.Q., Sun L., Cui J., Zhang L.J., Tang B., Huang F., Qin Q., Pei X.P., Zhou A.M., Shao L.M., Liu J.L., Zhang F.Y., Du W.D., Franke A., Bowcock A.M., Elder J.T., Liu J.J., Yang S., Zhang X.J. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 2010, 42:1005-1009.
134. Sun L.D., Li W., Yang S., Fan X., Yan K.L., Liang Y.H., Gao M., Cui Y., Xiao F.L., Du W.H., Zhang K.Y., Huang W., Liu J.J., Zhang X.J. Evidence for a novel psoriasis susceptibility locus at 9q33-9q34 in Chinese Hans. J. Invest. Dermatol. 2007, 127:1140-1144.
135. Sun L.D., Yang S., Liu J.J., Ren Y.Q., Fan X., Xu S.X., Zhou L., Yang C.J., Xiao F.L., Gao M., Cui Y., Du W.H., Huang W., Zhang X.J. Follow-up analysis of 180 Chinese Han families: identification of a novel locus for psoriasis at 2p22 3-11.2. Br. J. Dermatol. 2008, 158:512-517.
136. Suomela S., Kainu K., Onkamo P., Tiala I., Himberg J., Koskinen L., Snellman E., Karvonen S.L., Karvonen J., Uurasmaa T., Reunala T., Kivikas K., Jansen C.T., Holopainen P., Elomaa O., Kere J., Saarialho-Kere U. Clinical associations of the risk alleles of HLA-Cw6 and CCHCR1*WWCC in psoriasis. Acta Derm. Venereol. 2007, 87:127-134.
137. Tang H., Jin X., Li Y., Jiang H., Tang X., Yang X., Cheng H., Qiu Y., Chen G., Mei J., Zhou F., Wu R., Zuo X., Zhang Y., Zheng X., Cai Q., Yin X., Quan C., Shao H., Cui Y., Tian F., Zhao X., Liu H., Xiao F., Xu F., Han J., Shi D., Zhang A., Zhou C., Li Q., Fan X., Lin L., Tian H., Wang Z., Fu H., Wang F., Yang B., Huang S., Liang B., Xie X., Ren Y., Gu Q., Wen G., Sun Y., Wu X., Dang L., Xia M., Shan J., Li T., Yang L., Zhang X., He C., Xu A., Wei L., Gao X., Xu J., Zhang F., Zhang J., Sun L., Liu J., Chen R., Yang S., Wang J. A large-scale screen for coding variants predisposing to psoriasis. Nat. Genet. 2014, 46:45-50.
138. Tiala I., Wakkinen J., Suomela S., Puolakkainen P., Tammi R., Forsberg S., Rollman O., Kainu K., Rozell B., Kere J., Saarialho-Kere U., Elomaa O. The PSORS1 locus gene CCHCR1 affects keratinocyte proliferation in transgenic mice. Hum. Mol. Genet. 2008, 17:1043-1051.
139. Tomfohrde J., Silverman A., Barnes R., Fernandez-Vina M.A., Young M., Lory D., Morris L., Wuepper K.D., Stastny P., Menter A., et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994, 264:1141-1145.
140. Trembath R.C., Clough R.L., Rosbotham J.L., Jones A.B., Camp R.D., Frodsham A., Browne J., Barber R., Terwilliger J., Lathrop G.M., Barker J.N. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 1997, 6:813-820.
141. Trowbridge R.M., Pittelkow M.R. Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris. J. Drugs Dermatol. 2014, 13:111-118.
142. Tsoi L.C., Spain S.L., Knight J., Ellinghaus E., Stuart P.E., Capon F., Ding J., Li Y., Tejasvi T., Gudjonsson J.E., Kang H.M., Allen M.H., McManus R., Novelli G., Samuelsson L., Schalkwijk J., Stahle M., Burden A.D., Smith C.H., Cork M.J., Estivill X., Bowcock A.M., Krueger G.G., Weger W., Worthington J., Tazi-Ahnini R., Nestle F.O., Hayday A., Hoffmann P., Winkelmann J., Wijmenga C., Langford C., Edkins S., Andrews R., Blackburn H., Strange A., Band G., Pearson R.D., Vukcevic D., Spencer C.C., Deloukas P., Mrowietz U., Schreiber S., Weidinger S., Koks S., Kingo K., Esko T., Metspalu A., Lim H.W., Voorhees J.J., Weichenthal M., Wichmann H.E., Chandran V., Rosen C.F., Rahman P., Gladman D.D., Griffiths C.E., Reis A., Kere J., Nair R.P., Franke A., Barker J.N., Abecasis G.R., Elder J.T., Trembath R.C. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 2012, 44:1341-1348.
143. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., Asano N., Kishimoto M., Tanida Y., Kakinuma T., Mitsui H., Tada Y., Wakugawa M., Torii H., Komine M., Asahina A., Tamaki K. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 2002, 30:161-166.
144. Vasilopoulos Y., Walters K., Cork M.J., Duff G.W., Sagoo G.S., Tazi-Ahnini R. Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur. J. Hum. Genet. 2008, 16:1002-1009.
145. Veal C.D., Clough R.L., Barber R.C., Mason S., Tillman D., Ferry B., Jones A.B., Ameen M., Balendran N., Powis S.H., Burden A.D., Barker J.N., Trembath R.C. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J. Med. Genet. 2001, 38:7-13.
146. Villanova F., Di Meglio P., Nestle F.O. Biomarkers in psoriasis and psoriatic arthritis. Ann. Rheum. Dis. 2013, 72(Suppl. 2):ii104-ii110.
147. Vinson C., Chatterjee R. CG methylation. Epigenomics 2012, 4:655-663.
148. Ward J.H., Stephens F.E. Inheritance of psoriasis in a Utah kindred. Arch. Dermatol. 1961, 84:589-592.
149. Weger W., Hofer A., Wolf P., El-Shabrawi Y., Renner W., Kerl H., Salmhofer W. Role of the interleukin 15 96516A>T and IL15 96330C>A gene polymorphisms in Caucasian patients with chronic plaque psoriasis. J. Dermatol. Sci. 2008, 51:147-149.
150. Wu L.S., Li F.F., Sun L.D., Li D., Su J., Kuang Y.H., Chen G., Chen X.P., Chen X. A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population. Hum. Genet. 2011, 130:749-757.
151. Wuepper K.D., Coulter S.N., Haberman A. Psoriasis vulgaris: a genetic approach. J. Invest. Dermatol. 1990, 95:2S-4S.
152. Xu L., Li Y., Zhang X., Sun H., Sun D., Jia X., Shen C., Zhou J., Ji G., Liu P., Guan R., Yu Y., Jin Y., Bai J., Yu J., Fu S. Deletion of LCE3C and LCE3B genes is associated with psoriasis in a northern Chinese population. Br. J. Dermatol. 2011, 165:882-887.
153. Xu N., Brodin P., Wei T., Meisgen F., Eidsmo L., Nagy N., Kemeny L., Stahle M., Sonkoly E., Pivarcsi A. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J. Invest. Dermatol. 2011, 131:1521-1529.
154. Xu N., Meisgen F., Butler L.M., Han G., Wang X.J., Soderberg-Naucler C., Stahle M., Pivarcsi A., Sonkoly E. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J. Immunol. 2013, 190:678-688.
155. Yan K.L., Huang W., Zhang X.J., Yang S., Chen Y.M., Xiao F.L., Fan X., Gao M., Cui Y., Zhang G.L., Sun L.D., Wang P.G., Chen J.J., Li W., Chen Z.H., Wang Z.M., Wang D.Z., Zhang K.Y., Liu J.J. Follow-up analysis of PSORS9 in 151 Chinese families confirmed the linkage to 4q31-32 and refined the evidence to the families of early-onset psoriasis. J. Invest. Dermatol. 2007, 127:312-318.
156. Yang C.F., Hwu W.L., Yang L.C., Chung W.H., Chien Y.H., Hung C.F., Chen H.C., Tsai P.J., Fann C.S., Liao F., Chen Y.T. A promoter sequence variant of ZNF750 is linked with familial psoriasis. J. Invest. Dermatol. 2008, 128:1662-1668.
157. Yi R., O'Carroll D., Pasolli H.A., Zhang Z., Dietrich F.S., Tarakhovsky A., Fuchs E. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 2006, 38:356-362.
158. Yi R., Pasolli H.A., Landthaler M., Hafner M., Ojo T., Sheridan R., Sander C., O'Carroll D., Stoffel M., Tuschl T., Fuchs E. DGCR8-dependent microRNA biogenesis is essential for skin development. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:498-502.
159. Young C., Allen M.H., Cuthbert A., Ameen M., Veal C., Leman J., Burden A.D., Kirby B., Griffiths C.E., Trembath R.C., Mathew C.G., Barker J.N. A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Exp. Dermatol. 2003, 12:506-509.
160. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., Scheuch H., Angel P., Tschachler E., Wagner E.F. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.
161. Zhang K., Zhang R., Li X., Yin G., Niu X. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis. Eur. J. Dermatol. 2009, 19:141-146.
162. Zhang K., Zhang R., Li X., Yin G., Niu X., Hou R. The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin. Exp. Dermatol. 2007, 32:702-708.
163. Zhang P., Su Y., Chen H., Zhao M., Lu Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 2010, 60:40-42.
164. Zhang P., Su Y., Lu Q. Epigenetics and psoriasis. J. Eur. Acad. Dermatol. Venereol. 2012, 26:399-403.
165. Zhang P., Su Y., Zhao M., Huang W., Lu Q. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris. Eur. J. Dermatol. 2011, 21:552-557.
166. Zhang P., Zhao M., Liang G., Yin G., Huang D., Su F., Zhai H., Wang L., Su Y., Lu Q. Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J. Autoimmun. 2013, 41:17-24.
167. Zhang X.J., He P.P., Wang Z.X., Zhang J., Li Y.B., Wang H.Y., Wei S.C., Chen S.Y., Xu S.J., Jin L., Yang S., Huang W. Evidence for a major psoriasis susceptibility locus at 6p21(PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese hans. J. Invest. Dermatol. 2002, 119:1361-1366.
168. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., Zhang F.R., Zhang C., Du W.H., Pu X.M., Li H., Xiao F.L., Wang Z.X., Cui Y., Hao F., Zheng J., Yang X.Q., Cheng H., He C.D., Liu X.M., Xu L.M., Zheng H.F., Zhang S.M., Zhang J.Z., Wang H.Y., Cheng Y.L., Ji B.H., Fang Q.Y., Li Y.Z., Zhou F.S., Han J.W., Quan C., Chen B., Liu J.L., Lin D., Fan L., Zhang A.P., Liu S.X., Yang C.J., Wang P.G., Zhou W.M., Lin G.S., Wu W.D., Fan X., Gao M., Yang B.Q., Lu W.S., Zhang Z., Zhu K.J., Shen S.K., Li M., Zhang X.Y., Cao T.T., Ren W., Zhang X., He J., Tang X.F., Lu S., Yang J.Q., Zhang L., Wang D.N., Yuan F., Yin X.Y., Huang H.J., Wang H.F., Lin X.Y., Liu J.J. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 2009, 41:205-210.
169. Zhang X.J., Yan K.L., Wang Z.M., Yang S., Zhang G.L., Fan X., Xiao F.L., Gao M., Cui Y., Wang P.G., Sun L.D., Zhang K.Y., Wang B., Wang D.Z., Xu S.J., Huang W., Liu J.J. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J. Invest. Dermatol. 2007, 127:2544-2551.
170. Zhao M., Wang L.T., Liang G.P., Zhang P., Deng X.J., Tang Q., Zhai H.Y., Chang C.C., Su Y.W., Lu Q.J. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4T cells of psoriasis vulgaris. Clin. Immunol. 2013, 150:22-30.
171. Zhou J., Sun D., Xu L., Sun L., Fu S., Li Y. ADAM33 as a psoriasis susceptibility gene in the Han population of northeastern China. Dermatology 2011, 223:356-362.
172. Zhu K., Yin X., Tang X., Zhang F., Yang S., Zhang X. Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis. Rheumatol. Int. 2012, 32:1893-1900.
173. Zibert J.R., Lovendorf M.B., Litman T., Olsen J., Kaczkowski B., Skov L. MicroRNAs and potential target interactions in psoriasis. J. Dermatol. Sci. 2010, 58:177-185.